Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
97
NCT02309762
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of FB825 in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 31, 2015
Completion: Feb 29, 2016
NCT03758716
An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis
Phase: Phase 2
Start: Jul 3, 2017
Completion: Sep 19, 2019
NCT03890302
Evaluate the Safety, Tolerability, Pharmacokinetics,and Clinical Activity of FB704A
Start: Mar 14, 2019
Completion: May 27, 2020